# US 2026/0061213 A1 · Method and apparatus for oncomagnetic treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0061213 A1
- Document ID: US20260061213A1
- Status: Published application
- Kind: A1
- Application number: 19/378,179
- Filed: 2025-11-03
- Published: 2026-03-05
- Earliest claimed: 2020-06-19
- Assignees: The Methodist Hospital dba Houston Methodist Hospital
- Applicants: The Methodist Hospital Dba Houston Methodist Hospital
- Inventors: Santosh Anand Helekar; David Stuart Baskin; Martyn Alun Sharpe; Kumar Pichumani
- Web page: https://patentgrep.com/patent/US20260061213A1

## CPC

- A61N 2/004: {specially adapted for a specific therapy}
- A61N 2/06: using magnetic fields produced by permanent magnets (A61N2/12 takes precedence)
- A61N 2/12: using variable magnetic fields obtained by mechanical movement
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A device for cancer therapy comprises one or more means for producing a magnetic field, where the one or more means for producing a magnetic field oscillate on a first axis and a second axis substantially orthogonal to the first axis. The device further comprises a controller configured to oscillate the means for producing a magnetic field wherein the oscillating frequency reaches a maximum of 50-350 Hz, and, the oscillation of the one or more magnetic fields is at intervals such that the oscillation duration is in a range of 10 milliseconds to 5 seconds, and the duration of an interval between oscillations is in a range of 10 milliseconds to 10 minutes.

## Claims

### Claim 1

A device for cancer therapy, comprising:
one or more means for producing a magnetic field, wherein the one or more means for producing a magnetic field oscillate on a first axis and a second axis substantially orthogonal to the first axis,
a controller configured to oscillate the means for producing a magnetic field wherein the oscillating frequency reaches a maximum of 50-350 Hz, and, the oscillation of the one or more magnetic fields is at intervals such that the oscillation duration is in a range of 10 milliseconds to 5 seconds, and the duration of an interval between oscillations is in a range of 10 milliseconds to 10 minutes.

### Claim 2 (depends on 1)

The device of claim 1 wherein the one or more means for producing a magnetic field oscillate on a third axis substantially orthogonal to the first axis and the second axis.

### Claim 3 (depends on 1)

The device of claim 1 wherein the means for producing a magnetic field is a permanent magnet or an electromagnet.

### Claim 4 (depends on 3)

The device of claim 3 wherein the permanent magnet is a ferrite or rare earth magnet.

### Claim 5 (depends on 4)

The device of claim 4 wherein the rare earth magnet comprises neodymium or samarium and cobalt.

### Claim 6 (depends on 4)

The device of claim 4 wherein the magnet is a ferrite magnetostrictive magnet.

### Claim 7 (depends on 1)

The device of claim 1 wherein the controller controls the oscillation of the one or more means for producing a magnetic field to generate a series of pulses with a pulse length of approximately 250 milliseconds.

### Claim 8 (depends on 1)

The device of claim 1 wherein the controller controls the oscillation of the one or more means for producing a magnetic field to generate a series of pulses having a pulse interval of approximately 250 milliseconds.

### Claim 9 (depends on 1)

The device of claim 1 wherein the controller controls the rate of increase and decrease of the oscillating frequency.

### Claim 10 (depends on 1)

The device of claim 1 wherein an oscillating magnetic field generated by the oscillation has a peak to peak amplitude of 3 mT.

### Claim 11 (depends on 9)

The device of claim 9 wherein the controller decreases the oscillating frequency over a period of about 250 milliseconds.

### Claim 12 (depends on 9)

The device of claim 9 wherein the controller increases the oscillating frequency over a period of about 250 milliseconds.

### Claim 13

A method for disrupting mitochondrial function or inducing apoptosis or cell death in cancer cells in a tissue, the method comprising:
oscillating one or more magnetic fields wherein the oscillating frequency reaches a maximum of 50-350 Hz, wherein the one or more magnetic fields oscillate on a first axis and a second axis substantially orthogonal to the first axis, and wherein the one or more magnetic fields are in proximity to the tissue such that oscillating magnetic fields are generated within the tissue; and,
oscillating the one or more magnetic fields at intervals such that the oscillation duration is in a range of 10 milliseconds to 5 seconds, and the duration of an interval between oscillations is in a range of 10 milliseconds to 10 minutes.

### Claim 14 (depends on 13)

The method of claim 13 wherein the one or more magnetic fields oscillate on a third axis substantially orthogonal to the first axis and the second axis.

### Claim 15 (depends on 13)

The method of claim 13 wherein the one or more magnetic fields are generated by permanent magnets or electromagnets.

### Claim 16 (depends on 15)

The method of claim 15 wherein the permanent magnet is a ferrite or rare earth magnet.

### Claim 17 (depends on 16)

The method of claim 16 wherein the rare earth magnet comprises neodymium or samarium and cobalt.

### Claim 18 (depends on 16)

The method of claim 16 wherein the magnet is a ferrite magnetostrictive magnet.

### Claim 19 (depends on 13)

The method of claim 13 wherein the oscillating magnetic fields are generated as a series of pulses with a pulse length of approximately 250 milliseconds.

### Claim 20 (depends on 19)

The method of claim 19 wherein the series of pulses have a pulse interval of approximately 250 milliseconds.

### Claim 21 (depends on 13)

The method of claim 13 comprising decreasing the oscillating frequency over a period of about 250 milliseconds.

### Claim 22 (depends on 13)

The method of claim 13 comprising increasing the oscillating frequency over a period of about 250 milliseconds.

### Claim 23 (depends on 13)

The method of claim 13 wherein the oscillating magnetic fields have a peak to peak amplitude of 3 mT.

### Claim 24 (depends on 13)

The method of claim 13 wherein the oscillating magnetic fields increase the production of reactive oxygen species (ROS) and/or induce an alteration of electron flow in the tissue.
